Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately. (See "Society guideline links: Immune thrombocytopenia (ITP) and other platelet disorders" and "Society guideline links: von Willebrand disease" and "Society guideline links: Hemophilia A and B" and "Society guideline links: Acquired bleeding disorders" and "Society guideline links: Transfusion and patient blood management".)
International
●AABB: Evidence-based practice guidelines for plasma transfusion (2010)
Canada
●NAC: Framework for appropriate use and distribution of solvent detergent treated plasma in Canada (2015)
United States
●NHF: MASAC recommendations regarding doses of clotting factor concentrate in the home (2016)
●NHF: MASAC recommendations regarding physical therapy guidelines in patients with bleeding disorders (2015)
●Choosing Wisely: Don't use bleeding time test to guide patient care (2013)
●NHF: MASAC recommendations on administration of vaccines to individuals with bleeding disorders (2013)
●NHF: MASAC recommendations on use of COX-2 inhibitors in persons with bleeding disorders (2005)
●NHF: Transition guidelines for people with bleeding disorders (2003)
United Kingdom
●UKHCDO: Guidance on the dental management of patients with haemophilia and congenital bleeding disorders (2013, reviewed 2016)
●UKHCDO: Guideline for the diagnosis and management of the rare coagulation disorders (2014)
●UKHCDO: Emergency and out of hours care of patients with bleeding disorders – Standards of care for assessment and treatment (2009, reviewed 2013)
●BSH: Guidelines on fibrinogen assays (2003)
Australia-New Zealand
●AHCDO: A consensus statement on the dental treatment of patients with inherited bleeding disorders (2010)
●AHCDO: Guidelines for the management of factor VII deficiency (2010)
●AHCDO: Guidelines for the treatment of congenital disorders of fibrinogen (2010)